论文部分内容阅读
目的:探讨恶性肿瘤特异生长因子(tumor specific growth factor,TSGF)在恶性肿瘤治疗中的应用价值。方法:对我院2010年2月至2014年2月接收的350例恶性肿瘤患者的血清TSGF检测结果进行统计,作为观察组与正常对照组进行对比,其中观察组的80例恶性肿瘤患者治疗前后接受了血清中TSGF检测,用以判定治疗效果。结果:观察组恶性肿瘤患者血清中的TSGF水平显著高于正常对照组,两组比较有显著差异(P<0.05),其中80例恶性肿瘤患者经过治疗,其血清中TSGF的含量与治疗前相比明显降低,有显著差异(P<0.05)。结论:血清TSGF检测对恶性肿瘤患者的早期诊断和疗效观察具有较高的临床意义,值得推广。
Objective: To investigate the value of tumor specific growth factor (TSGF) in the treatment of malignant tumors. Methods: The serum TSGF results of 350 patients with malignant tumors received from February 2010 to February 2014 in our hospital were statistically analyzed. The results were compared between the observation group and the normal control group, in which 80 cases of malignant tumor patients in the observation group before and after treatment Received TSGF serum test to determine the treatment effect. Results: Serum levels of TSGF in patients with malignant tumors were significantly higher than those in normal controls (P <0.05). Among 80 patients with malignant tumors, the levels of TSGF in serum before treatment Than the significantly reduced, there was a significant difference (P <0.05). Conclusion: Serum TSGF detection of malignant tumors in patients with early diagnosis and treatment of high clinical significance, it is worth promoting.